Karen Lewis, Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 5,000 shares at $75.00 ($375K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($375k) by Chief People Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2025-01-21 | $37K | — | Filing → |
| APLS | SELL | 2025-01-14 | $46K | — | Filing → |
| APLS | SELL | 2024-01-31 | $139K | — | Filing → |